Market Place
Sourcing Support
All News #Library
Apotex Receives FDA Warning Letter
11 Nov 2025 //
FDA
Health Canada Issues Recalls of Apotex`s Quetiapine
31 Jan 2025 //
HEALTH CANADA
Health Canada Issues Apotex recalls Apo-Acyclovir tablets due to a nitrosamine impurity
28 Apr 2022 //
HEALTH CANADA
Health Canada Issues Recall of Apotex Inc`s Elavil 10mg
27 Jan 2022 //
HEALTH CANADA
Health Canada Issues Recall of Apotex`s Mirvala 28 tablets
30 Sep 2021 //
HEALTH CANADA
Health Canada Issues Recall of Apotex`s APO-Metformin
17 Apr 2020 //
HEALTH CANADA
Health Canada Issues Recall of Apotex Inc`s APO-Metformin
05 Feb 2020 //
HEALTH CANADA
Health Canada Issues Recall of Apotex Inc`s APO-Losartan Tablet
11 Mar 2019 //
HEALTH CANADA
Health Canada Issues Recall of Apotex`s Prednisone Tablets
20 Dec 2018 //
HEALTH CANADA
Apotex Research PVT Ltd Receives FDA Warning Letter
15 Aug 2018 //
FDA
Enforcement Report - Week of June 13, 2018
13 Jun 2018 //
FDA
Apotex Research Private Limited On FDA Import Alert List
13 Apr 2018 //
FDA
Apotex Inc Issues Recall of Alysena 28 (Levonorgestrel and Ethinyl Estradiol Tablets)
13 Feb 2018 //
HEALTH CANADA
Apotex And The TGA Are Advising Of A Recall Of A Batch Of Metformin
22 Jan 2018 //
TGA
Apotex Research Private Limited (ARPL) On Health Canda Inspection List
23 Dec 2017 //
HEALTH CANADA
Apotex Research Private Limited Fails EDQM Inspection
19 Dec 2017 //
EDQM
Apotex Inc Issues Recall of Apo-Amoxi Pwr For Susp 125mg/5ml
01 Sep 2017 //
HEALTH CANADA
Enforcement Report - Week of May 10, 2017
10 May 2017 //
FDA
Apotex Inc. Voluntary Recalls Apo-Sertraline
16 Jan 2017 //
HEALTH CANADA
Apotex Recalls Naproxen Sodium
13 Dec 2016 //
HEALTHY CANADIANS
US FDA Enforcement report - 16/Mar/2016
16 Mar 2016 //
FDA
Apotex Recalls Norfloxacin 400 mg as level of excipients do not meet the quantities specified in the regulatory filing
01 Sep 2015 //
HEALTHY CANADIANS
Apotex Recalls Fluoxetine as API may not meet the specification for impurity- isobutyl vinyl ketone
01 Sep 2015 //
HEALTHY CANADIANS
Apotex initiated recall of one additional lot of APO-Candesartan
05 May 2015 //
HEALTH CANADA
J&J recalls contraceptives for subpotency
24 Apr 2015 //
FIERCE PHARMA MANUFACTURING
Apotex Product Recalled by Health Canada
13 Apr 2015 //
HEALTHY CANADIANS
FDA Issues Another Warning Letter to Apotex Over Manufacturing Problems
03 Feb 2015 //
PHARMALOT
Apotex Research receives warning letter due to cGMP deviations
30 Jan 2015 //
FDA
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.